Literature DB >> 6381097

Spatial arrangement of the three alpha helices in the solution conformation of E. coli lac repressor DNA-binding domain.

E R Zuiderweg, M Billeter, R Boelens, R M Scheek, K Wüthrich, R Kaptein.   

Abstract

The relative orientations of the 3 helices in the DNA-binding domain ('headpiece') of lac repressor have been determined using distance constraints obtained from 2-dimensional 1H nuclear Overhauser enhancement spectra. The relative orientations of its helices is similar to that of the central 3 helices in the DNA-binding domain of the lambda repressor of the bacteriophage lambda.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381097     DOI: 10.1016/0014-5793(84)81166-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Orientation of the Lac repressor DNA binding domain in complex with the left lac operator half site characterized by affinity cleaving.

Authors:  J A Shin; R H Ebright; P B Dervan
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

2.  Lac repressor-Lac operator complexes. Solution X-ray scattering and electrophoretic studies.

Authors:  F Culard; M Charlier; J C Maurizot; A Tardieu
Journal:  Eur Biophys J       Date:  1987       Impact factor: 1.733

3.  Ribosomal protein L7/L12 has a helix-turn-helix motif similar to that found in DNA-binding regulatory proteins.

Authors:  P A Rice; T A Steitz
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

4.  Secondary structure determination for the Antennapedia homeodomain by nuclear magnetic resonance and evidence for a helix-turn-helix motif.

Authors:  G Otting; Y Q Qian; M Müller; M Affolter; W Gehring; K Wüthrich
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

5.  Isolation and sequence-specific DNA binding of the Antennapedia homeodomain.

Authors:  M Müller; M Affolter; W Leupin; G Otting; K Wüthrich; W J Gehring
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.